The effects of phosphatidylserine on endocrine response to moderate intensity exercise

Phosphatidylserine (PS) is a naturally occurring phospholipid nutrient that is most concentrated in organs with high metabolic activity, such as the brain, lungs, heart, liver, and skeletal muscle. PS is located mainly in the internal layer of the cell membrane and has a variety of unique regulatory and structural functions. PS modulates the activity of receptors, ion channels, enzymes and signaling molecules and is involved in governing membrane fluidity [1]. Traditionally, PS supplements were derived from bovine cortex (BC-PS); however, due to the potential transfer of infectious diseases, soy-derived PS (S-PS) has been established as a safe alternative [2]. PS has been shown to improve a variety of brain functions that tend to decline with age [3]. In recent studies, PS has been shown to enhance mood in a cohort of young people during mental stress [4] and to improve accuracy during tee-off by increasing the golfer's stress resistance [5].

An excessive cortisol response to exercise-induced stress has been linked to a negative training state, which could lead to overreaching or overtraining [6]. During early stages of overtraining muscles become sore, submaximal and resting heart rate increase and testosterone levels fall. The body has difficulties in adjusting, but usually recovers with a few days' rest. Chronic overtraining often creates a disturbance in the anabolic-catabolic balance, which may express itself in decreased performance, injury, depressed immunity and psychological depression [7].

PS has been demonstrated to speed up recovery, prevent muscle soreness, improve well-being, and might possess ergogenic properties in athletes involved in cycling, weight training and endurance running [8]. PS has been reported to be an effective supplement for combating exercise-induced stress and preventing the physiological deterioration that accompanies too much exercise. BC-PS has been reported to attenuate serum cortisol and adrenocorticotropic hormone (ACTH) responses to staged cycling exercise. 800 mg BC-PS supplementation lowered cortisol response by 30%, whereas 400 mg showed no significant results compared to placebo [9]. Also, 800 mg S-PS has been reported to reduce the cortisol response to intensive resistance training by 20% [10]. PS had no effect on testosterone levels [10]. These finding suggest that PS partly counteracts the stress-induced activation of the hypothalamo-pituitary-adrenal (HPA) axis [11].

Studies using less than 800 mg of S-PS supplementation showed beneficial effects on performance and markers of muscle damage. 750 mg of S-PS resulted in an increased time to exhaustion during stage intermittent cycling exercise [12], and tended to improve sprint and exercise performances during exhaustive intermittent running when compared to placebo [13]. 600 mg and 300 mg S-PS significantly lowered creatine kinase levels 24-hours after a 90-min run [14]; however, none of the studies showed an effect on cortisol response, establishing the effective dose at 800 mg S-PS per day for short-term application (10–15 days). A recent study reported positive effects on emotional response to a mental and emotional stressor after the supplementation of a soy lecithin complex. 400 mg per day resulted in a pronounced blunting of serum ACTH and cortisol levels compared to placebo; yet, higher doses (600 mg and 800 mg) did not result in the same effects [15].

The purpose of the current study was to investigate the efficacy of short-term S-PS supplementation, at dosage levels less than the currently established dose, on cortisol, testosterone, lactate, and growth hormone response to acute moderate-intensity exercise.

Figure 1 shows the effects of S-PS or placebo supplementation on cortisol, testosterone, lactate and growth hormone response to exercise-induced stress at -30, 0, 15, 20, 30, 40, 60, and 80 minutes after exercise. Mean peak concentrations are shown in table 2.

S-PS supplementation resulted in significant lower plasma cortisol levels at the beginning of the exercise (p = 0.002) when compared to placebo. Differences for testosterone (p = 0.20) and growth hormone levels (p = 0.30) were not significant.

S-PS supplementation reduced plasma cortisol concentrations by 39 ± 1% when compared with placebo (treatment effect: F = 6.7, p = 0.03; treatment × time interaction effect: F = 8.3, p = 0.05). Plasma testosterone concentrations increased with S-PS (51 ± 6%) when compared with placebo; however, differences between groups failed to reach statistical significance for the effect of treatment (F = 2.79, p = 0.13) and treatment × time interaction effect (F = 0.35, p = 0.87). Exercise resulted in an increase in lactate levels in both groups, however, the increase failed to reach statistical significance (time effect: F = 5.41, p = 0.06). Supplementation did not result in significant differences in lactate response between the S-PS and placebo groups (treatment effect: F = 0.47, p = 0.51; treatment × time effect: F = 1.62, p = 0.34). Similarly, supplementation did not influence plasma growth hormone concentrations (treatment effect: F = 2.49, p = 0.15) or the pattern of response (treatment × time interaction effect: F = 0.75, p = 0.66).

S-PS supplementation resulted in a favorable physiological state when compared to the placebo group. Area under the curve analysis (figure 2) showed significant differences between S-PS and placebo for cortisol (35 ± 0% reduction, p < 0.01), testosterone (37 ± 5% increase, p = 0.02), and testosterone to cortisol ratio (184 ± 5% increase, p = 0.02, figure 2).

Supplementation with 600 mg of S-PS per day for 10 days blunted cortisol response before and during exercise-induced stress. Activation of the hypothalamo-pituitary-adrenal (HPA) axis has been proposed as the mechanism by which PS blunts cortisol production. The current theories assert that this may be accomplished by possibly altering receptor ligands interactions or corticotrophin releasing factor (CRF) receptor interactions [17–20]. By decreasing CRF there would be a decrease in ACTH, thereby decreasing cortisol secretion. It has been proposed the result of chronic treatment with PS alters CRF receptor interactions resulting in reduced activation of the HPA axis after stress [9]. Another possibility is that acute exercise-induced stress influences the secretagogue arginine vasopressin (AVP). Exercise of duration shorter than 15 minutes and intensities that exceed 65% of peak VO_{2 max} have been demonstrated to influence AVP to a greater degree [21, 22]. Therefore, a 600 mg per day dose of PS may also inhibit the release of AVP, which would decrease ACTH and subsequently cortisol.

While S-PS supplementation resulted in lower cortisol responses than placebo, it was associated with higher testosterone levels which were within the normal range of 3–10 ng/ml for male subjects. The results of this study support evidence from previous research that high cortisol levels impair male biosynthesis of testosterone in the testes, which might help explain why AUC for plasma testosterone was higher following supplementation with S-PS when compared to placebo [23, 24]. As S-PS supplementation increased the AUC for testosterone and decreased the AUC for cortisol, supplementation caused a significant positive impact on the T/C ratio of the participants. A reduction in the T/C ratio has been reported to indicate a state of overtraining or negative state, whereas an elevation in the T/C ratio appears to indicate a more positive state [7, 25]. The S-PS phase had cortisol AUC levels that were significantly lower than the placebo phase. Consequently, S-PS supplementation gave rise to what could be considered a positive physiological state [15]. The results of this study suggest that 600 mg/d of S-PS might have the potential to avert an overtrained state.

Not all research supports these conclusions. In a recent investigation observing the effects of S-PS on oxidative stress following intermittent running, the cortisol response was not attenuated [13]. The key differences between this investigation and previous studies are the intensity of exercise and daily dose used during supplementation. Previous studies utilized stress levels up to an 85% peak VO_{2 max} while this study stressed the individuals to exhaustion [13]. This suggests that phosphatidylserine administration may have a rate-limited effect that is dependent upon the intensity level which indicates that the effect is based on a nutritional improvement rather than a pharmacological effect. Phosphatidylserine has been shown to improve enzymatic activity [26] by improving membrane fluidity and composition [27]. PS plays a significant role in the maintenance of neuronal excitability and message transfer potentially resulting in a reduced need for adrenergic stimulation at moderate intensity exercise levels.

The GH and lactate results of this study are consistent with findings in previous literature [9, 10]. Growth hormone responses varied little and were not significantly different between the S-PS and the placebo phase. This suggests the mechanism that influences the dynamics of the hypothalmo-pituitary axis with regards to GH release appear to be unaffected by PS administration. Exercise caused increases in plasma lactate concentrations during both trials and supplementation did not influence these concentrations; therefore, the participants exercised at similar workloads during both phases of the study.

The potential of PS as an alternative nutritional strategy for disorders that are associated with cortisol over-production has not been investigated, suggesting that there is a need for further research in the use of PS as a potential aid for overtraining and as an aid in exercise related activities. Furthermore, this study, along with previous literature, demonstrates that PS can influence neuroendocrine function; consequently, the possibility exists that PS might be a beneficial nutrient in conditions such as obesity and type 2 diabetes.

PS supplementation with 600 mg per day for 10 days blunts the cortisol response to exercise-induced stress. In addition, PS significantly increases the testosterone to cortisol ratio. These findings suggest that PS is an effective supplement for combating exercise-induced stress. PS supplementation promotes a desirable hormonal balance for athletes and might attenuate the physiological deterioration that accompanies overtraining and/or overstretching.